1156 related articles for article (PubMed ID: 19070661)
1. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
Maeda H; Bharate GY; Daruwalla J
Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
[TBL] [Abstract][Full Text] [Related]
2. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.
Greish K
Methods Mol Biol; 2010; 624():25-37. PubMed ID: 20217587
[TBL] [Abstract][Full Text] [Related]
3. Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP
Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
[TBL] [Abstract][Full Text] [Related]
4. Advances in polymeric micelles for drug delivery and tumor targeting.
Kedar U; Phutane P; Shidhaye S; Kadam V
Nanomedicine; 2010 Dec; 6(6):714-29. PubMed ID: 20542144
[TBL] [Abstract][Full Text] [Related]
5. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.
Maruyama K
Adv Drug Deliv Rev; 2011 Mar; 63(3):161-9. PubMed ID: 20869415
[TBL] [Abstract][Full Text] [Related]
6. Passive tumor targeting of soluble macromolecules and drug conjugates.
Seymour LW
Crit Rev Ther Drug Carrier Syst; 1992; 9(2):135-87. PubMed ID: 1386002
[TBL] [Abstract][Full Text] [Related]
7. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects.
Maeda H
Bioconjug Chem; 2010 May; 21(5):797-802. PubMed ID: 20397686
[TBL] [Abstract][Full Text] [Related]
8. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.
Maeda H
J Control Release; 2012 Dec; 164(2):138-44. PubMed ID: 22595146
[TBL] [Abstract][Full Text] [Related]
9. Exploiting the enhanced permeability and retention effect for tumor targeting.
Iyer AK; Khaled G; Fang J; Maeda H
Drug Discov Today; 2006 Sep; 11(17-18):812-8. PubMed ID: 16935749
[TBL] [Abstract][Full Text] [Related]
10. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
Greish K; Nagamitsu A; Fang J; Maeda H
Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
[TBL] [Abstract][Full Text] [Related]
11. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
Lukyanov AN; Torchilin VP
Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
[TBL] [Abstract][Full Text] [Related]
12. Design and development of polymer conjugates as anti-angiogenic agents.
Segal E; Satchi-Fainaro R
Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248
[TBL] [Abstract][Full Text] [Related]
13. Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors.
Nagamitsu A; Greish K; Maeda H
Jpn J Clin Oncol; 2009 Nov; 39(11):756-66. PubMed ID: 19596662
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Taurin S; Nehoff H; Greish K
J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
[TBL] [Abstract][Full Text] [Related]
16. Tumoritropic and lymphotropic principles of macromolecular drugs.
Maeda H; Matsumura Y
Crit Rev Ther Drug Carrier Syst; 1989; 6(3):193-210. PubMed ID: 2692843
[TBL] [Abstract][Full Text] [Related]
17. [Targeting of anti-cancer drugs with nano-sized carrier system].
Yokoyama M; Okano T
Nihon Rinsho; 1998 Dec; 56(12):3227-34. PubMed ID: 9883646
[TBL] [Abstract][Full Text] [Related]
18. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications.
Maeda H; Fang J; Inutsuka T; Kitamoto Y
Int Immunopharmacol; 2003 Mar; 3(3):319-28. PubMed ID: 12639809
[TBL] [Abstract][Full Text] [Related]
19. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).
Tanaka T; Shiramoto S; Miyashita M; Fujishima Y; Kaneo Y
Int J Pharm; 2004 Jun; 277(1-2):39-61. PubMed ID: 15158968
[TBL] [Abstract][Full Text] [Related]
20. Polymeric drug delivery systems for localized cancer chemotherapy.
De Souza R; Zahedi P; Allen CJ; Piquette-Miller M
Drug Deliv; 2010 Aug; 17(6):365-75. PubMed ID: 20429844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
